Additional region of rpoB (202-260) for rapid detection of rifampicine resistant of M. tuberculosis by PCR-SSCP

S. I. Tatkov, E. M. Kozhina, O. U. Smirnova, Y. V. Tumanov, E. V. Medvedeva, A. P. Duntau (Koltsovo, Novosibirsk, Russia)

Source: Annual Congress 2001 - Drug resistant TB
Session: Drug resistant TB
Session type: Oral Presentation
Number: 3468
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. I. Tatkov, E. M. Kozhina, O. U. Smirnova, Y. V. Tumanov, E. V. Medvedeva, A. P. Duntau (Koltsovo, Novosibirsk, Russia). Additional region of rpoB (202-260) for rapid detection of rifampicine resistant of M. tuberculosis by PCR-SSCP. Eur Respir J 2001; 16: Suppl. 31, 3468

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Molecular fingerprinting of mycobacterium tuberculosis isolates in new cases of tuberculosis using mycobacterial interspersed repetitive unit–variable number tandem repeat genotyping (MIRU-VNTR) – Epidemiology of drug resistant tuberculosis in Greece
Source: Annual Congress 2010 - Clinical tuberculosis
Year: 2010

Detection of fluoroquinolones resistance mutations in mycobacterium tuberculosis by hydrolysis probes and RFLP
Source: Annual Congress 2013 –Diagnostic features of tuberculosis II
Year: 2013


Detection of isoniazid resistance mutations in Mycobacterium tuberculosis by use of sequencing, PCR-RFLP and TaqMan probes
Source: Annual Congress 2010 - Tuberculosis drug resistance
Year: 2010

Diagnostic of sensitivity mycobacterium tuberculosis strains to isoniazid and rifampicin by simultaneous identification of mutations in rpoB, katG, inhA and ahpC-oxyR genes with biological microchips
Source: Eur Respir J 2006; 28: Suppl. 50, 379s
Year: 2006

Mechanisms of heteroresistance to isoniazid and rifampin of Mycobacterium tuberculosis in Tashkent, Uzbekistan
Source: Eur Respir J 2009; 33: 368-374
Year: 2009



Line probe assay (LiPA) based rapid detection of multiple drug resistent (MDR) mycobacterium tuberculosis (MTB)
Source: Annual Congress 2012 - Microbiological advances in the diagnosis of tuberculosis
Year: 2012


23S rRNA mutations in linezolid-resistant clinical isolates of M. tuberculosis: A report of two cases
Source: Annual Congress 2013 –Diagnostic features of tuberculosis II
Year: 2013

A case series of pyrazinamide mono-resistant mycobacterium tuberculosis using whole genome sequencing for diagnosis and cluster linkage.
Source: International Congress 2018 – Drug-resistant tuberculosis and the sequelae of pulmonary tuberculosis
Year: 2018


Detection of isoniazid or rifampin resistant Mycobacterium tuberculosis in patients with cavity and previously treated for tuberculosis - usefulness of rapid drug susceptibility test with sputum samples by reverse hybridization assay
Source: Annual Congress 2005 - Resistant and multidrug resistant tuberculosis
Year: 2005


PCR-SSCP analysis for rapid detection of rifampicine resistance in clinical samples from TB patients
Source: Eur Respir J 2001; 18: Suppl. 33, 497s
Year: 2001

Application of the novel technique next gene sequencing for the determination of mycobacterium tuberculosis resistance in clinical samples
Source: Annual Congress 2013 –Tuberculosis diagnosis
Year: 2013

Molecular analysis of mutations in genes associated with multidrug-resistance in Mycobacterium tuberculosis isolates from patients with tuberculosis in Moscow region, Russia
Source: International Congress 2018 – Drug-resistant tuberculosis
Year: 2018



Real time polymerase chain reaction (RT-PCR) based rapid detection of multi-drug resistant (MDR) mycobacterium tuberculosis (MTB)
Source: Annual Congress 2011 - Novel strategies for the diagnosis of tuberculosis
Year: 2011


A katG 315 mutation alone should not lead to exclusion of isoniazid in treatment of multidrug-resistant tuberculosis
Source: Eur Respir J, 50 (4) 1701696; 10.1183/13993003.01696-2017
Year: 2017



Rapid molecular detection of rifampicin and isoniazid resistance and identification of mutations in resistant genes of multi-drug resistant tuberculosis (MDR-TB) patients
Source: Annual Congress 2011 - Novel strategies for the diagnosis of tuberculosis
Year: 2011


Relationship between rpoB mutations and minimum inhibitory concentrations of rifampicin in multi drug resistant strains of mycobacterium tuberculosis
Source: Annual Congress 2011 - Tuberculosis: from bench to bedside
Year: 2011

Bio-Chip (BCh) technology for diagnostics of multidrug resistance (DR) of mycobacterium tuberculosis (MBT) from patients with disseminated tuberculosis (DT)
Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis
Year: 2008


Detection of first and second line drug resistance mutations from multi drug resistant mycobacterium tuberculosis strains by Ion Torrent whole genome sequencing (WGS)
Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments
Year: 2016


Rapid genotypic assays for detection the rifampin and isoniazid resistance in M. tuberculosis strains and clinical specimens in Moldova
Source: Annual Congress 2010 - Emerging drug resistance in tuberculosis
Year: 2010

Systematic evaluation of clarithromycin (CLA) resistance associated mutations in Mycobacterium abscessus complex based on whole-genome sequencing analysis and drug susceptibility testing.
Source: Virtual Congress 2020 – Translational science in respiratory infections
Year: 2020